Erdosteine is a multimechanism, mucolytic agent that decreases the sputum viscoelastic properties and bacterial adhesion to the cell membrane, endowed with bronchial anti-inflammatory activity and ...

Erdosteine is manufactured by Edmond Pharma (Milan, Italy) and commercialized in 42 countries in Europe and worldwide under different trade names (e.g., Erdotin ®, Erdomed ® and Mucotec ...

New York, United States , Jan. 15, 2023 (GLOBE NEWSWIRE) -- The Global Erdosteine Market Size to grow from USD 120.00 million in 2021 to USD 228.14 million by 2030, at a Compound Annual Growth ...

Learn everything you need to know about Erdosteine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions ...

The Food and Drug Administration (FDA) has recently granted the Orphan Drug Status to Erdosteine , molecule discovered and developed by the R&D division of the Italian pharmaceutical company ...

today announced that the Office of Orphan Products Development (OOPD) of the Food and Drug Administration (FDA) has granted orphan drug designation for its drug candidate, Erdosteine®, for the ...

The finished Erdosteine product is manufactured by Daewoong Pharmaceutical at its Korean facilities. Under the terms of the new agreement, Daewoong will annually purchase minimum API ...

Details concerning the Erdosteine medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and injections.